Curated News
By: NewsRamp Editorial Staff
April 10, 2025
Calidi Biotherapeutics Names Dr. Guy Travis Clifton as Chief Medical Officer to Advance Clinical Development of CLD-201 Virotherapy
TLDR
- Dr. Guy Travis Clifton appointed CMO at Calidi Biotherapeutics, enhancing clinical development of virotherapy for solid tumors.
- Calidi Biotherapeutics focuses on stem cell-based platforms carrying oncolytic viruses to combat cancer, improving efficacy and patient safety.
- Calidi's innovative cancer therapies aim to treat and prevent metastatic diseases, offering hope for patients worldwide.
- Dr. Clifton's 17 years of oncology expertise and leadership roles bring valuable insights to cancer therapy development at Calidi Biotherapeutics.
Impact - Why it Matters
This news matters as it highlights the strategic appointment of an experienced oncologist to lead the development of innovative cancer therapies. The advancement of CLD-201 could potentially revolutionize treatment options for solid tumors, offering hope for improved patient outcomes and enhanced efficacy.
Summary
Calidi Biotherapeutics appoints Dr. Guy Travis Clifton as Chief Medical Officer, Consultant and Advisor to advance clinical development of CLD-201, a virotherapy for solid tumors. Dr. Clifton brings over 17 years of oncology and clinical trial expertise to bolster Calidi's efforts in developing stem cell-based and enveloped virus cancer therapies.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, Calidi Biotherapeutics Names Dr. Guy Travis Clifton as Chief Medical Officer to Advance Clinical Development of CLD-201 Virotherapy
